Robin Sanderson

16PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursComparative language studiesInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 03, 2026
Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.

|Mar 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Mar 08, 2026
Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival.

Maeve A O'Reilly, William Wilson, Bernard Maybury

|Mar 04, 2026
Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT.

Nicole Santoro, Jarl Eduard Mooyaart, Urban Novak

|Nov 25, 2025
Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene-engineered advanced cell therapy products for treatment of haematological disorders.

S Ghorashian, R Sanderson, J Lee

|Oct 29, 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Tom van Meerten, Marie José Kersten, Gloria Iacoboni

Pageof 3

Frequent Collaborators

8 joint publications

Andrea Kuhnl

5 joint publications

Claire Roddie

4 joint publications

Emil Kumar

4 joint publications

Frances Seymour